O Abramsky, A Carmon, S Lavy. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adrenergic beta-Antagonists/therapeutic useAdultAgedDihydroxyphenylalanine/therapeutic useFemaleHumansMaleMiddle AgedParasympatholytics/therapeutic useParkinson Disease/drug therapyPropranolol/therapeutic use
Substances: See more » Adrenergic beta-AntagonistsParasympatholyticsDihydroxyphenylalaninePropranolol
Year: 1971 PMID: 4399459 DOI: 10.1016/0022-510x(71)90183-3
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181